Kyndryl Investors Face April 13 Deadline to Seek Lead Role in Securities Class Actions

Overview

• Investors who bought Kyndryl shares between August 1, 2024 and February 9, 2026 have until April 13, 2026 to move for appointment as lead plaintiff.
• Multiple cases are pending in federal court in New York, including first‑filed Brander v. Kyndryl in the Eastern District and a later case that broadened the class period.
• Complaints allege materially misstated financials and ineffective controls, including claims that executives boosted free cash flow by deferring vendor payments.
• Kyndryl disclosed it could not timely file its December 31, 2025 Form 10‑Q, anticipated reporting material weaknesses tied to information and communication and tone at the top, and received voluntary document requests from the SEC’s Division of Enforcement.
• The company announced the immediate departures of its CFO and general counsel as the stock fell to $10.59 on February 9, 2026, and it said prior internal‑control assessments and the auditor’s FY2025 opinion should no longer be relied upon.